How Insurer-Pharmacy Negotiations Set Generic Drug Prices in the U.S.
Generic drugs make up 90% of prescriptions but only 23% of U.S. drug spending-yet many insured patients pay more than cash buyers. This is how PBM negotiations and spread pricing drive hidden costs.
View More